NCT05171816 2026-03-11Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer (China Cohort)AstraZenecaPhase 3 Active not recruiting110 enrolled 12 charts
NCT07365995 2026-01-26A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerBioNTech SEPhase 3 Not yet recruiting736 enrolled